These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7936118)
21. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats. Shankar RP; Karan RS; Handu SS; Bhargava VK Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627 [TBL] [Abstract][Full Text] [Related]
22. Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area. Gillies DM; Mylecharane EJ; Jackson DM Eur J Pharmacol; 1996 May; 303(1-2):1-12. PubMed ID: 8804905 [TBL] [Abstract][Full Text] [Related]
23. The 5-HT₂C receptor agonist, lorcaserin, and the 5-HT₆ receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour. Higgs S; Cooper AJ; Barnes NM Psychopharmacology (Berl); 2016 Feb; 233(3):417-24. PubMed ID: 26507195 [TBL] [Abstract][Full Text] [Related]
25. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Dourish CT; Hutson PH; Curzon G Psychopharmacology (Berl); 1985; 86(1-2):197-204. PubMed ID: 3161115 [TBL] [Abstract][Full Text] [Related]
26. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats. Szumlinski KK; Frys KA; Kalivas PW Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437 [TBL] [Abstract][Full Text] [Related]
27. Evidence for the involvement of the 5-HT1A receptor in CCK induced satiety in rats. Voigt JP; Fink H; Marsden CA Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):217-20. PubMed ID: 7609773 [TBL] [Abstract][Full Text] [Related]
28. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice. Umathe SN; Bhutada PS; Raut VS; Jain NS; Mundhada YR Behav Pharmacol; 2009 Feb; 20(1):78-83. PubMed ID: 19106764 [TBL] [Abstract][Full Text] [Related]
29. Contrasting effects of 5-HT Pratt WE; Lin P; Pierce-Messick Z; Ilesanmi AO; Clissold KA Behav Brain Res; 2017 Apr; 323():15-23. PubMed ID: 28115218 [TBL] [Abstract][Full Text] [Related]
30. Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Rodgers RJ Physiol Behav; 2004 Mar; 81(1):129-40. PubMed ID: 15059692 [TBL] [Abstract][Full Text] [Related]
31. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors. Hewson G; Leighton GE; Hill RG; Hughes J Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561 [TBL] [Abstract][Full Text] [Related]
32. Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze. Vasar E; Peuranen E; Oöpik T; Harro J; Männistö PT Psychopharmacology (Berl); 1993; 110(1-2):213-8. PubMed ID: 7870888 [TBL] [Abstract][Full Text] [Related]
33. The anorectic effect of SK&F 38393, a selective dopamine D1 receptor agonist: a microstructural analysis of feeding and related behaviour. Cooper SJ; Francis J; Rusk IN Psychopharmacology (Berl); 1990; 100(2):182-7. PubMed ID: 1968277 [TBL] [Abstract][Full Text] [Related]
34. Effect of the 5-HT3 receptor antagonist ondansetron on hypothalamic self-stimulation in rats and its interaction with the CCK analogue caerulein. Herberg LJ; De Belleroche JS; Rose IC; Montgomery AM Neurosci Lett; 1992 Jun; 140(1):16-8. PubMed ID: 1407694 [TBL] [Abstract][Full Text] [Related]
35. On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination. Wright FL; Rodgers RJ Psychopharmacology (Berl); 2014 Feb; 231(4):787-800. PubMed ID: 24114428 [TBL] [Abstract][Full Text] [Related]
36. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures. Mongeau R; De Montigny C; Blier P Eur J Pharmacol; 1994 May; 256(3):269-79. PubMed ID: 8045271 [TBL] [Abstract][Full Text] [Related]
37. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine. King GR; Joyner CM; Ellinwood EH Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757 [TBL] [Abstract][Full Text] [Related]
38. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Kitchener SJ; Dourish CT Psychopharmacology (Berl); 1994 Jan; 113(3-4):369-77. PubMed ID: 7862847 [TBL] [Abstract][Full Text] [Related]
39. Differential effects of ondansetron and alpha-flupenthixol on responding for conditioned reward. Fletcher PJ; Higgins GA Psychopharmacology (Berl); 1997 Nov; 134(1):64-72. PubMed ID: 9399368 [TBL] [Abstract][Full Text] [Related]
40. Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intake. Savastano DM; Carelle M; Covasa M Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1499-508. PubMed ID: 15718390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]